A comparison of cisplatin and carboplatin: a short review
Fujita, Y.; Seki, N.; Inoue, K.; Miyazawa, T.; Eguchi, K.
West Indian Medical Journal 59(1): 115
2010
ISSN/ISBN: 0043-3144 PMID: 20931930 Document Number: 638046
Document emailed within 1 workday
Related Documents
Willemse, P.H.; Blom van Assendelft, P.H.; Fontein, D.L.; Kloppenburg, M.; Boonstra, H.; de Vries, E.G. 1991: Carboplatin in the treatment of ovarian carcinoma; as effective and less toxic in comparison with cisplatin Nederlands Tijdschrift Voor Geneeskunde 135(35): 1588-1592Bosl, G.J.; Bajorin, D.F. 1994: Etoposide plus carboplatin or cisplatin in good-risk patients with germ cell tumors: a randomized comparison Seminars in Oncology 21(5 Suppl 12: 61-64
Olawaiye, A.B.; Godoy, H.E.; Shahzad, M.M.K.; Rauh-Hain, J.A.; Lele, S.B.; Odunsi, K. 2012: Comparison of outcomes in patients treated with multi-agent regiments of cisplatin, adriamycin, and VP-16 versus carboplatin and paclitaxel for advanced and recurrent endometrial cancer European Journal of Gynaecological Oncology 33(5): 477-479
Skarlos, D.V.; Aravantinos, G.; Kosmidis, P.; Athanassiadis, A.; Stathopoulos, G.P.; Pavlidis, N.; Bafaloukos, D.; Karphathios, S.; Papakostas, P.; Bamia, C.; Fountzilas, G. 1997: Paclitaxel with carboplatin versus paclitaxel with carboplatin alternating with cisplatin as first-line chemotherapy in advanced epithelial ovarian cancer: preliminary results of a Hellenic Cooperative Oncology Group study Seminars in Oncology 24(5 Suppl 15: S15
Geffen, D.B.; Cohen, Y. 1995: Cisplatin and carboplatin--update Harefuah 129(3-4): 131-135
Adam, Z.; Mayer, J.; Hájek, R. 1994: Cisplatin and carboplatin in the treatment of malignant lymphoma and multiple myeloma Vnitrni Lekarstvi 40(12): 790-800
Natale, R.B. 2003: Irinotecan, cisplatin/carboplatin, and COX-2 inhibition in small-cell lung cancer Oncology 17(7 Suppl. 7): 22-26
Lund, B.; Hansen, O.P.; Hansen, H.H.; Hansen, M. 1992: Combination therapy with carboplatin/cisplatin/ifosfamide/etoposide in ovarian cancer Seminars in Oncology 19(1 Suppl 1: 26-29
Elferink, F.; van der Vijgh, W.J.; Klein, I.; Pinedo, H.M. 1986: Interaction of cisplatin and carboplatin with sodium thiosulfate: reaction rates and protein binding Clinical Chemistry 32(4): 641-645
Smith, I.E.; Harland, S.J.; Robinson, B.A.; Evans, B.D.; Goodhart, L.C.; Calvert, A.H.; Yarnold, J.; Glees, J.P.; Baker, J.; Ford, H.T. 1985: Carboplatin: a very active new cisplatin analog in the treatment of small cell lung cancer Cancer Treatment Reports 69(1): 43-46
Hosaka, M.; Ebina, Y.; Moriwaki, M.; Hara, Y.; Araki, N.; Todo, Y.; Takeda, M.; Watari, H.; Sakuragi, N. 2007: Successful desensitization using cisplatin after carboplatin-associated hypersensitivity reactions in 3 cases with recurrent ovarian carcinoma Gan to Kagaku Ryoho. Cancer and ChemoTherapy 34(9): 1505-1508
Kiyama, Y.; Suzuki, G.; Masauzi, N.; Ohizumi, H.; Kobayashi, N.; Ogasawara, M.; Naohara, T.; Saito, M.; Higa, T.; Kasai, M. 1996: Two cases of relapse or refractory germ cell tumor who had been treated with combination chemotherapy of cisplatin and carboplatin Gan to Kagaku Ryoho. Cancer and ChemoTherapy 23(14): 1989-1992
Iwasaki, K.; Komuro, Y.; Masumoto, N.; Asaoka, K.; Ishitani, K. 1999: A case of advanced ovarian clear cell adenocarcinoma responding to cisplatin-cyclophosphamide and paclitaxel-carboplatin Gan to Kagaku Ryoho. Cancer and ChemoTherapy 26(10): 1483-1486
Gadducci, A.; Facchini, V.; Dell'Arciprete, T.; Del Bravo, B.; Galigani, P.; Palla, R.; Fioretti, P. 1988: Evaluation of the renal function in patients with ovarian carcinoma subjected to polychemotherapy including cisplatin or carboplatin Minerva Ginecologica 40(1): 33-38
Yoshimura, A.; Yamano, Y.; Gemma, A.; Yoshimori, K.; Hayashihara, K.; Taniguchi, Y.; Uematsu, K.; Shibuya, M.; Kudoh, S.; Niitani, H. 1993: An early phase Ii trial combining cisplatin and carboplatin in advanced non-small cell lung cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 20(4): 503-508
Coughlin, C.T.; Richmond, R.C. 1989: Biologic and clinical developments of cisplatin combined with radiation: concepts, utility, projections for new trials, and the emergence of carboplatin Seminars in Oncology 16(4 Suppl 6: 31-43
Shimoya, K.; Kunishige, I.; Okuno, Y.; Hayashi, S.; Komura, H.; Arimoto, Y.; Otsuki, Y. 2001: A case of papillary adenocarcinoma of the ovary that responded favorably to irinotecan hydrochloride and cisplatin after the administration of paclitaxel and carboplatin Gan to Kagaku Ryoho. Cancer and ChemoTherapy 28(6): 845-848
Sukhaboon, J.; Porapakkhan, P.; Penpattanagul, S. 2009: Randomized comparison of fluorouracil plus cisplatin vs. cisplatin as an adjunct to radiation therapy in stage IIB-IVA squamous cell carcinoma of the cervix: pilot study Journal of the Medical Association of Thailand 92(8): 1072-1076
Calvert, A.H.; Newell, D.R.; Gore, M.E. 1992: Future directions with carboplatin: can therapeutic monitoring, high-dose administration, and hematologic support with growth factors expand the spectrum compared with cisplatin? Seminars in Oncology 19(1 Suppl 2: 155-163
Ji, Y.; Peng, T.; Wang, G.; Zhang, Y.; Cao, M.; Gao, Q.; Li, S. 2018: Short-term efficacy and safety of the synchronous neoadjuvant chemoradiotherapy with paclitaxel plus carboplatin in stage IIi adenocarcinoma of esophagogastric junction Zhonghua Wei Chang Wai Ke Za Zhi 21(9): 1019-1024